Current Drug Targets
Title:Impaired Quality Control of Mitochondria Underlying the Pathogenesis of Alzheimer's Disease
Volume: 22 Issue: 14
Author(s): Md. Sahab Uddin*, Umme Tabassum Arobi Katha and Ghulam Md. Ashraf*
Affiliation:
- Department of Pharmacy, Southeast University, Dhaka,Bangladesh
- Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah,Saudi Arabia
Export Options
About this article
Cite this article as:
Uddin Sahab Md. *, Katha Tabassum Arobi Umme and Ashraf Md. Ghulam *, Impaired Quality Control of Mitochondria Underlying the Pathogenesis of Alzheimer's Disease, Current Drug Targets 2021; 22 (14) . https://dx.doi.org/10.2174/1389450122666210309105326
DOI https://dx.doi.org/10.2174/1389450122666210309105326 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hormonal Control of the Neuropeptide Y System
Current Protein & Peptide Science Current Status and Perspectives in Peptide Receptor Radiation Therapy
Current Pharmaceutical Design PTI-609: A Novel Analgesic that Binds Filamin A to Control Opioid Signaling
Recent Patents on CNS Drug Discovery (Discontinued) Eremurus spectabilis, Rich Source of Isoorientin: Isolation, Quantification and Anti-Cancer Activity on SH-SY5Y Neuroblastoma Cells
Current Pharmaceutical Analysis Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Current Neurovascular Research Heterogeneity Amongst 5-HT3 Receptor Subunits: Is this Significant?
Current Molecular Medicine Environmental Risk Assessment of Replication Competent Viral Vectors Applied in Clinical Trials: Potential Effects of Inserted Sequences
Current Gene Therapy Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models
Current Hypertension Reviews Synthetic Lethality to Overcome Cancer Drug Resistance
Current Medicinal Chemistry Saponins as Tool for Improved Targeted Tumor Therapies
Current Drug Targets Aptamers as Targeting Delivery Devices or Anti-cancer Drugs for Fighting Tumors
Current Drug Metabolism Vitamins B1, B2, B3 and B9 – Occurrence, Biosynthesis Pathways and Functions in Human Nutrition
Mini-Reviews in Medicinal Chemistry Non-B DNA Structures as Candidate Drug Targets Against Structural Chromosomal Instability
Current Pharmacogenomics and Personalized Medicine Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
Current Pharmaceutical Biotechnology FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
Current Diabetes Reviews Procarbazine – A Traditional Drug in the Treatment of Malignant Gliomas
Current Medicinal Chemistry Sevoflurane But Not Propofol Provided Dual Effects of Cell Survival in Human Neuroblastoma SH-SY5Y Cells
Current Alzheimer Research Prodigiosins as Anti Cancer Agents: Living Upto Their Name
Current Pharmaceutical Design Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents
Current Drug Targets Atypical PKCι as Target for Glioblastoma Therapy
Current Cancer Drug Targets